GR3023047T3 - Hybrid plasminogen activators - Google Patents

Hybrid plasminogen activators

Info

Publication number
GR3023047T3
GR3023047T3 GR970400714T GR970400714T GR3023047T3 GR 3023047 T3 GR3023047 T3 GR 3023047T3 GR 970400714 T GR970400714 T GR 970400714T GR 970400714 T GR970400714 T GR 970400714T GR 3023047 T3 GR3023047 T3 GR 3023047T3
Authority
GR
Greece
Prior art keywords
plasminogen activators
hybrid plasminogen
human
amino acid
subsequences
Prior art date
Application number
GR970400714T
Other languages
English (en)
Inventor
Bhanu Dr Rajput
Bhabatosh Dr Chaudhuri
Fredericus Alphonsu Asselbergs
Bernd Dr Meyhack
Jutta Dr Heim
Oostrum Jan Dr Van
Sefik Prof Dr Alkan
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629153A external-priority patent/GB8629153D0/en
Priority claimed from GB878709656A external-priority patent/GB8709656D0/en
Priority claimed from GB878715890A external-priority patent/GB8715890D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of GR3023047T3 publication Critical patent/GR3023047T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Amplifiers (AREA)
  • Adhesives Or Adhesive Processes (AREA)
GR970400714T 1986-12-05 1997-04-04 Hybrid plasminogen activators GR3023047T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868629153A GB8629153D0 (en) 1986-12-05 1986-12-05 Hybrid proteins
GB878701160A GB8701160D0 (en) 1986-12-05 1987-01-20 Hybrid proteins
GB878709656A GB8709656D0 (en) 1986-12-05 1987-04-23 Hybrid proteins
GB878715890A GB8715890D0 (en) 1986-12-05 1987-07-06 Hybrid proteins

Publications (1)

Publication Number Publication Date
GR3023047T3 true GR3023047T3 (en) 1997-07-30

Family

ID=27449853

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400714T GR3023047T3 (en) 1986-12-05 1997-04-04 Hybrid plasminogen activators

Country Status (17)

Country Link
EP (1) EP0277313B1 (el)
JP (2) JP2641875B2 (el)
AT (1) ATE148167T1 (el)
AU (1) AU621281B2 (el)
CA (1) CA1341479C (el)
CY (1) CY2156B1 (el)
DE (1) DE3752008T2 (el)
DK (1) DK175483B1 (el)
ES (1) ES2095825T3 (el)
FI (1) FI100106B (el)
GR (1) GR3023047T3 (el)
HK (1) HK1005037A1 (el)
IE (1) IE81116B1 (el)
IL (1) IL84700A (el)
NO (1) NO177603C (el)
NZ (1) NZ222793A (el)
PT (1) PT86276B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204255A (en) * 1986-01-31 1993-04-20 Sagami Chemical Research Center Hybrid tissue plasminogen activator/urokinase polypeptides
MY103358A (en) * 1987-04-15 1993-06-30 Novartis Ag Process for the production of protiens.
AU1893988A (en) * 1987-07-13 1989-01-19 Collaborative Research Inc. Nonglycosylated plasminogen activator and method of preparation
FR2637600B1 (fr) * 1988-10-11 1992-03-06 Pasteur Institut Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques
AU4502589A (en) * 1988-10-27 1990-05-14 Upjohn Company, The Thrombolytic agents with modified kringle domains
GB8826975D0 (en) * 1988-11-18 1988-12-21 Beecham Group Plc Novel compounds
DE3923339A1 (de) * 1989-05-31 1990-12-06 Boehringer Mannheim Gmbh Gewebs-plasminogen-aktivator-derivat
IE901849A1 (en) * 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator
GB8919803D0 (en) * 1989-09-01 1989-10-18 Ciba Geigy Pharmaceutical compositions
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
EP0462651A1 (en) * 1990-06-15 1991-12-27 Leuven Research & Development V.Z.W. Chimeric plasminogen activators
DE69222013T2 (de) * 1991-12-16 1998-01-29 Ciba Geigy Ag Endoplasmatisches Retikulum-ständige rekombinante dibasische Endoprotease und deren Verwendungen
JPH07143877A (ja) * 1993-10-01 1995-06-06 Sumitomo Pharmaceut Co Ltd 新規なｔ−ＰＡ類似体
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
KR101393946B1 (ko) 2005-10-21 2014-05-12 카탈리스트 바이오사이언시즈, 인코포레이티드 보체 활성화를 억제하는 변형된 프로테아제
EP2046951B1 (en) 2006-07-05 2011-10-26 Catalyst Biosciences, Inc. Protease screening methods and proteases identified thererby

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
EP0231883B1 (en) * 1986-01-31 1992-09-02 Sagami Chemical Research Center Hybrid plasminogen activator-like polypeptide
EP0293394B2 (en) * 1986-01-31 2003-10-29 Genetics Institute, LLC Novel thrombolytic proteins

Also Published As

Publication number Publication date
DE3752008T2 (de) 1997-08-14
FI100106B (fi) 1997-09-30
PT86276B (pt) 1990-11-07
FI875324A (fi) 1988-06-06
JPH09117292A (ja) 1997-05-06
DK638187D0 (da) 1987-12-04
NO177603B (no) 1995-07-10
JP2641875B2 (ja) 1997-08-20
AU621281B2 (en) 1992-03-12
DK175483B1 (da) 2004-11-08
IE873299L (en) 1988-06-05
NO177603C (no) 1995-10-18
NZ222793A (en) 1990-09-26
IE81116B1 (en) 2000-03-22
CY2156B1 (en) 2002-08-23
ATE148167T1 (de) 1997-02-15
FI875324A0 (fi) 1987-12-02
EP0277313A1 (en) 1988-08-10
DE3752008D1 (de) 1997-03-06
NO875069D0 (no) 1987-12-04
PT86276A (en) 1988-06-01
IL84700A (en) 1992-11-15
DK638187A (da) 1988-06-06
JPS63160581A (ja) 1988-07-04
EP0277313B1 (en) 1997-01-22
AU8209187A (en) 1988-06-16
CA1341479C (en) 2005-04-12
IL84700A0 (en) 1988-05-31
NO875069L (no) 1988-06-06
HK1005037A1 (en) 1998-12-18
ES2095825T3 (es) 1997-03-01
JP2645237B2 (ja) 1997-08-25

Similar Documents

Publication Publication Date Title
HK1005037A1 (en) Hybrid plasminogen activators
DE68929551D1 (de) Menschliche DNase
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
HK1008823A1 (en) Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production
EP0259475A4 (en) RECOMBINANT HUMAN ENDOTHEL CELL GROWTH FACTOR.
EP0314415A3 (en) Interleukin-7
EP0288307A3 (en) Recombinant production of pdgf a-chain polypeptides
NZ224243A (en) Single chain urokinase type plasminogen activator with yeast type glycosylation and site directed mutants thereof
EP0343132A3 (en) Methods and systems for producing hiv antigens
EP0165759A3 (en) Mammalian promotors useful in yeast expression
MX9709455A (es) Polinucleotidos de adenosina-cinasa.